The incidence of melanoma in the United States continues to rise, with nearly 90,000 new cases projected for 2017, 25 percent of which will occur in people younger than 40 years. Melanoma accounts for just one percent of all skin cancer diagnoses but is the primary cause of skin cancer mortality, responsible for almost 10,000 US deaths annually. Although melanoma can arise de novo, approximately half of all cases develop from a preexisting pigmented lesion. Read the full story & the medicine behind it.CME Credit Form
The highly skilled physicians of IU Health Physicians are featured in Advanced Praxis case studies exhibiting the latest clinical trends in medicine.Subscribe to Advanced Praxis Newsletter
AF is the most common sustained cardiac arrhythmia, affecting an estimated 2.7 to 6.1 million people in the United States, or approximately two percent of individuals <65 years and nine percent of those ≥65 years. Aside from increasing age and family history, hypertension is the greatest risk factor for AF, accounting for more than one-fifth of all cases. Read the full story & the medicine behind it.
Prostate cancer is the most common noncutaneous cancer among US males.1 In 2016, nearly 181,000 new cases were diagnosed, and more than 26,000 men died from the disease. The strongest risk factors are age (rates increase until age 70 and decline thereafter), positive family history (having an affected first-degree relative elevates risk two-fold), and black race. Read the full story & the medicine behind it.CME Credit Form
An estimated six percent of US adults have BE,1 a condition in which metaplastic columnar mucosa replaces the stratified esophageal squamous epithelium.2 Metaplasia is often a response to chronic inflammation, with GERD linked to a 10 to 15 percent risk. Other risk factors for BE include hiatal hernia, age >50 years, male gender, white race, cigarette smoking, family history, and central obesity. Read the full story & the medicine behind it.
Pancreatic cancer is one of the most aggressive and lethal malignancies, with median survival less than one year and fewer than five percent of patients alive five years after diagnosis. Today, the disease is the fourth leading cause of US cancer-related deaths and is predicted to move up to second by 2020 and rank first by 2025. The American Cancer Society estimates that in 2016, 53,000 people will be diagnosed with pancreatic cancer, and nearly 42,000 will die of the disease. Read the full story & the medicine behind it.CME Credit Form